Your source for the latest medtech news from AdvaMed® and our members.
Today, AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the introduction of the bipartisan Verifying Accurate, Leading-edge IVCT Development (VALID) Act. Introduced in…
Today, AdvaMed, The Medtech Association®, applauded the introduction in the House and Senate of the bipartisan Saving Access to Laboratory Services Act (SALSA) by Senators Sherrod Brown (D-OH) and Thom…
Today, AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the introduction of the bipartisan Ensuring Patient Access to Critical Breakthrough Products Act. The…
AdvaMedDx®, a division of AdvaMed® representing more than 75 manufacturers of innovative in vitro diagnostic (IVD) tests and technologies in the U.S. and abroad, announced today that Thierry Bernard, CEO…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
The European Union Council approved legislative changes to the Medical Device Regulation (EU MDR), finalizing a 3-4 ½ year extension on implementation of the new rules for certifying medical devices.…
AdvaMed®, the largest global trade organization representing medical technology companies, released the medtech industry’s “Medical Innovation Agenda for the 118th Congress.” These policy priorities would advance AdvaMed®’s goal to help…
RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX™ biology-guided radiotherapy, a cutting-edge treatment applicable…
The Advanced Medical Technology Association® (AdvaMed®), the largest trade association representing medical device manufacturers, including all major radiation therapy manufacturers in the U.S. and abroad. released the following statement from…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX™ biology-guided radiotherapy, a cutting-edge treatment applicable…